Intraoperative Ultrasound as a Decision-Making Tool in Modern Gynecologic Oncology
review
OA: gold
CC0
AI-generated summary
Intraoperative ultrasound enhances gynecologic oncology surgery by improving tumor localization, increasing complete resection rates, reducing lymphadenectomies, and aiding fertility preservation, despite learning curves and cost barriers.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Background: Intraoperative ultrasound (IOUS) is revolutionizing gynecologic oncology surgery by overcoming the limitations of traditional imaging and intraoperative assessment. Its real-time, high-resolution capabilities address critical needs in tumor localization, fertility preservation, refined intraoperative decisions, and complete cytoreduction. Methods: We reviewed clinical studies (1998–2024) evaluating IOUS applications, analyzing data on detection accuracy, surgical outcomes, and implementation challenges from peer-reviewed literature and institutional experiences. Results: IOUS demonstrates 88–93% sensitivity for subcentimeter metastases, refining surgical decisions in 25–40% of cases. Key outcomes include increased complete resection rates (68% to 87%), a 38% reduction in unnecessary lymphadenectomies, and successful fertility preservation in 92% of cases. Limitations include learning curves, 12% false-negative rate for micrometastases, and significant capital investment cost barriers. Conclusions: IOUS represents a transformative advance in precision surgery, improving both oncologic outcomes and quality of life. While standardization and accessibility challenges remain, ongoing technological innovations promise to solidify its role as a surgical standard.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (48)
- Classification and staging of malignant tumours in the female pelvis via crossref
- doi:10.11152/mu-3845 via crossref
- doi:10.1016/s0022-5347(17)65180-2 via crossref
- doi:10.4081/aiua.2018.3.195 via crossref
- doi:10.1259/bjr.20201406 via crossref
- doi:10.1155/2017/6141734 via crossref
- doi:10.3390/diagnostics14090942 via crossref
- doi:10.1016/j.ajog.2016.07.024 via crossref
- doi:10.1002/uog.20138 via crossref
- doi:10.1097/igc.0000000000001096 via crossref
- doi:10.1002/uog.20234 via crossref
- doi:10.1016/j.clon.2018.04.006 via crossref
- doi:10.1097/igc.0000000000001363 via crossref
- doi:10.3390/jcm11040953 via crossref
- doi:10.1097/igc.0b013e31821a35ef via crossref
- doi:10.1007/s00404-020-05957-w via crossref
- doi:10.1007/s12325-025-03165-z via crossref
- doi:10.18632/oncotarget.23021 via crossref
- doi:10.3332/ecancer.2020.1031 via crossref
- doi:10.1016/0090-8258(92)90099-5 via crossref
- doi:10.1136/bcr-2023-259501 via crossref
- doi:10.1002/uog.23358 via crossref
- doi:10.1002/uog.928 via crossref
- doi:10.3390/cancers15215281 via crossref
- doi:10.1006/gyno.2000.5820 via crossref
- doi:10.1259/bjr.20210117 via crossref
- doi:10.4329/wjr.v8.i3.288 via crossref
- doi:10.1097/01.aog.0000192407.04428.bb via crossref
- doi:10.1016/j.ygyno.2017.09.001 via crossref
- doi:10.1016/j.gore.2016.05.006 via crossref
- doi:10.1002/uog.5366 via crossref
- doi:10.3390/cancers14225528 via crossref
- doi:10.1186/s41747-022-00302-z via crossref
- doi:10.3390/medicina61020199 via crossref
- doi:10.3390/cancers11081044 via crossref
- doi:10.3389/fsurg.2024.1403741 via crossref
- doi:10.4254/wjh.v8.i11.513 via crossref
- doi:10.14366/usg.15014 via crossref
- doi:10.3390/cancers15072113 via crossref
- doi:10.3390/diagnostics13050971 via crossref
- doi:10.3390/diagnostics12020507 via crossref
- doi:10.1002/ajum.12221 via crossref
- doi:10.1111/1759-7714.15027 via crossref
- doi:10.2106/00004623-199911000-00013 via crossref
- doi:10.1007/s00404-022-06659-1 via crossref
- W1950018664 via openalex
- doi:10.1016/s0140-6736(58)91905-6 via crossref
- W4285392939 via openalex
SciLite annotations
organisms 1
noordeloos 2009062
chemicals 1
indocyanine green
Source provenance
- crossref
- last seen: 2026-05-16T01:00:08.806724+00:00
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- scilite
- last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0
· commercial use OK